FREE Account Opening + No Clearing Fees
Loading...
March 31, 2023 - April 10, 2023

Ajanta Pharma Limited Buyback (Ajanta Pharma Buyback 2023) Detail

Incorporated in 1979, Ajanta Pharma Limited is a specialty pharmaceutical company offering quality medicines across more than 30 countries in the world.

The company understands its customers' requirements and develops products to suit their needs with the help of cutting-edge technology to present innovative solutions.

The business of Ajanta Pharma includes Branded Generics in India and Emerging Markets in Asia and Africa; Generics in the USA; and Institution Sales in Africa. With diversified revenue streams, their business model is highly scalable and sustainable.

Ajanta Pharma operates through its 7 state-of-the-art manufacturing facilities situated in India. 6 of the company's facilities manufacture finished formulations and 1 manufactures Active Pharmaceutical Ingredients (APIs) primarily for captive consumption. The high-quality medicines of the company are trusted by healthcare professionals and patients in over 30 countries.

Ajanta Pharma Buyback 2023 Detail

Issue PeriodMarch 31, 2023 - April 10, 2023
Security NameAjanta Pharma Limited
Issue TypeTender Offer
Issue Size (Shares)2,210,500
Issue Size (Amount)₹315.00 Crores
Buyback Price₹1425 per share
Face Value₹2 per share
Listing AtBSE, NSE

Ajanta Pharma Buyback 2023 Issue Timetable

Last Date to buy sharesMarch 23, 2023
Record DateMarch 24, 2023
Offer Opens OnMarch 31, 2023
Last Date for receipt of Tender FormsApril 10, 2023
Offer Closes On *April 10, 2023
Finalisation of Buyback AcceptanceApril 13, 2023
Last Date for settlment of bidsApril 18, 2023
Last Date for Extinguishment of SharesApril 27, 2023

Buyback Ratio

CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders20 Equity Shares out of every 99 Fully paid-up Equity Shares held on the Record Date.331,575.00
General Category for all other Eligible Shareholders3 Equity Shares out of every 202 Fully paid-up Equity Shares held on the Record Date.1,878,925.00

Company Financials

Ajanta Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-202,680.06467.70
31-Mar-213,778.722,915.67653.87
31-Mar-224,055.583,456.67712.68
Amount in ₹ Crore

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1,252.00 4,523.00 1,197.49
Jan-2023 1,222.90 3,168.00 1,186.12
Dec-2022 1,272.00 1,192.00 1,210.90

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1,254.00 1,151.35 1,198.12
Jan-2023 1,224.00 1,150.00 1,186.49
Dec-2022 1,266.25 1,150.25 1,210.19

Necessity of the Issue

The buyback is being undertaken for the following reasons:

  1. The buyback will help the company to return surplus cash to its equity shareholders broadly in proportion to their shareholding, thereby enhancing the overall return to shareholders.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit a large number of public shareholders who would get classified as "small shareholders".
  3. The buyback may help in improving return on equity, reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.
  5. The buyback may lead to a reduction in outstanding Equity Shares, an improvement in earnings per equity share, and an enhanced return on equity.

Ajanta Pharma Buyback 2023 Documents

Ajanta Pharma Buyback 2023 Rating

4
3.5
Rating:Rated 3.5 stars
Vote Here ...

Ajanta Pharma Buyback 2023 Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Ajanta Pharma Limited
Ajanta House, Charkop,
Kandivali West,
Mumbai 400 067

Phone: +91 22 6606 1000
Email: investorgrievance@ajantapharma.com
Website: http://www.ajantapharma.com/

Ajanta Pharma Buyback 2023 Registrar

  1. Link Intime India Private Ltd
       Link Intime India Private Ltd
       C 101, 247 Park, L.B.S.Marg,
       Vikhroli (West), Mumbai - 400083

    Phone: +91-22-4918 6270
    Email: ajantapharma2023.buyback@linkintime.co.in
    Website: https://linkintime.co.in/initial_offer/public-issues.html

Ajanta Pharma Buyback 2023 Manager

Lead Manager(s)

  1. Edelweiss Financial Services Ltd

Registered Broker

  1. Nuvama Wealth Management Limited
    Email: instops@nuvama.com

Find Ajanta Pharma Buyback 2023 Latest Update

Ajanta Pharma Buyback 2023 FAQs

The Ajanta Pharma Buyback 2023 opens on March 31, 2023, and closes on April 10, 2023.

Last date to be eligible to participate in buyback is March 23, 2023.

The Ajanta Pharma Buyback 2023 is a Tender Offer.

Ajanta Pharma Buyback 2023 Schedule

Buyback Opening DateMarch 31, 2023
Buyback Closing DateApril 10, 2023
Last Date for receipt of Tender FormsApril 10, 2023
Finalisation of Buyback AcceptanceApril 13, 2023
Last Date for settlment of bidsApril 18, 2023
Last Date for Extinguishment of SharesApril 27, 2023

The Ajanta Pharma Buyback 2023 is being offered at Rs ₹1425 per share per equity share.

CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders20 Equity Shares out of every 99 Fully paid-up Equity Shares held on the Record Date.331,575.00
General Category for all other Eligible Shareholders3 Equity Shares out of every 202 Fully paid-up Equity Shares held on the Record Date.1,878,925.00

The record date for the Ajanta Pharma Buyback 2023 is March 24, 2023.

The issue size of Ajanta Pharma Buyback 2023 is of 2,210,500 equity shares at ₹1425 per share aggregating upto ₹315.00 Crores.

The buyback is being undertaken for the following reasons:

  1. The buyback will help the company to return surplus cash to its equity shareholders broadly in proportion to their shareholding, thereby enhancing the overall return to shareholders.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit a large number of public shareholders who would get classified as "small shareholders".
  3. The buyback may help in improving return on equity, reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.
  5. The buyback may lead to a reduction in outstanding Equity Shares, an improvement in earnings per equity share, and an enhanced return on equity.

All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.

The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.

The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.

The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.

The Ajanta Pharma Buyback 2023 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.


14 Comments

14. Ritik     Link|April 28, 2023 2:17:47 PM
Buyback me mere share ni uthaye ab kya karu. Please advise me.
13. Ritik     Link|April 28, 2023 2:15:48 PM
Buyback share nhi uthaye ab kya kru.
12. Neeraj     Link|April 22, 2023 9:47:47 AM
Buyback money not credit in my bank account till today dt 22.4.23 time 9.47 am
11. Gaurang     Link|April 19, 2023 1:21:38 PM
240 account 1 share accepted in all
10. Rajan     Link|April 18, 2023 9:51:42 PM
I have not received the buyback money although my 1 share has been accepted.
9. Naresh     Link|April 18, 2023 7:05:47 PM
Buyback complete 1 shareholding worked. Share gone
8. Prashant     Link|April 6, 2023 5:54:02 PM
what is the acceptance latest status for small shareholder ?
8.1. KAMMA SIVA RAMA KRISHNA   I Like It. 1|  Link|April 12, 2023 2:30:19 PM
I am hopefully looking forward for the AR between 40% to 50%.
8.2. KAMMA SIVA RAMA KRISHNA     Link|April 17, 2023 5:45:24 PM
61/135 I.e., 45% AR
7. KAMMA SIVA RAMA KRISHNA     Link|April 17, 2023 5:17:57 PM
AR is around 45%
6. Satish Kumar     Link|April 16, 2023 2:38:13 PM
Any information regarding AjantaPharma share buyback status
5. Newbie     Link|April 14, 2023 4:11:31 AM
Has anyone recieved an intimation regarding number of accepted shares ? The deadline for Buyback Ratio finalisation was supposed to be April 13.
4. Helloji     Link|March 14, 2023 11:34:34 AM
There is no guarantee one share strategy will work. You are assuming number of small shareholders won't change. Suppose that 1 crore investors buy 1 share each between now and record date. Then there is no way that all of them will be able to sell 1 share each.
4.1. bhagyesh     Link|March 18, 2023 7:55:25 PM
i have working since 2 years one share is buyback is working with me
4.2. Kiran     Link|April 13, 2023 8:10:04 AM
Absolutely true...
1 share strategy did not work in Indoamart & Bharat Rasayan for me...
3. Dhiraj Kumar     Link|April 3, 2023 3:31:45 PM
What is the Settlement ID and CM ID of Ajanta Pharma for Buyback 2023.
2. Kousik Chakravarti     Link|March 28, 2023 11:54:56 AM
AJANTA PHARMA BUYBACK DATES ANNOUNCED
1. Date of Board Meeting approving the proposal for the Buyback
Friday March 10, 2023
2. Date of Public Announcement for the Buyback
Monday March 13, 2023
3. Date of publication of the Public Announcement for the Buyback in newspapers
Tuesday March 14, 2023
4. Record Date for determining the names of the Eligible Shareholders and the Buyback Entitlement
Friday March 24, 2023
5. Filing of Letter of Offer
Tuesday March 28, 2023
6. Buyback Opening Date
Friday March 31, 2023
7. Buyback Closing Date
Monday April 10,2023
8. Last date of receipt of completed Tender Forms and other specified documents including physical share certificates (if and as applicable) by the Registrar to the Buyback
Monday April 10, 2023
9. Last date of verification of Tender Forms by
Registrar to the Buyback
Thursday April 13, 2023
10. Last date of intimation to the Designated Stock Exchange regarding Acceptance/ non-acceptance of Equity Shares by the Registrar to the Buyback
Monday April 17, 2023
11. Last date of completion of settlement of bids by the Clearing Corporation/ Stock Exchanges
Tuesday April 18, 2023
12. Last date of dispatch of share certificate(s) by the Registrar to the Buyback unblocking/ return of unaccepted Demat Shares by the Stock Exchanges to Eligible Shareholders/Seller Broker
Tuesday April 18, 2023
13. Last date of payment of consideration to Eligible Shareholders who participated in the Buyback
Tuesday April 18, 2023
14. Last date of extinguishment of the Equity Shares bought back
Thursday April 27, 2023
1. Kousik Chakravarti   I Like It. 1|  Link|March 10, 2023 9:08:18 PM
1 share strategy will surely work here like vrl,sportking,symphony and hgs.The calculation regarding 1 share strategy for small shareholders is explained in comment no 1.6 of hinduja global solutions buyback.

Compare Buybacks with Ajanta Pharma Buyback 2023